Molecular-guided PET/MRI (Positron Emission Tomography/Magnetic Resonance Imaging) to target hypoxia in Glioblastoma (GBM): A Pilot Study.

Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2017
This article has no abstract
Epistemonikos ID: b7d253615c2aa3c388efa6ba519038d6766abbcd
First added on: Feb 23, 2025